What is Scotiabank’s Forecast for Albemarle FY2026 Earnings?

Albemarle Corporation (NYSE:ALB) – Stock analysts at Scotiabank dropped their FY2026 earnings per share (EPS) estimates for shares of Albemarle in a research note issued on Tuesday, February 17th. Scotiabank analyst B. Isaacson now expects that the specialty chemicals company will post earnings per share of $8.38 for the year, down from their previous forecast of $9.57. Scotiabank currently has a “Sector Outperform” rating and a $200.00 price objective on the stock. The consensus estimate for Albemarle’s current full-year earnings is ($0.04) per share. Scotiabank also issued estimates for Albemarle’s FY2027 earnings at $9.96 EPS.

Albemarle (NYSE:ALB) last posted its quarterly earnings data on Wednesday, February 11th. The specialty chemicals company reported ($0.53) earnings per share for the quarter, missing the consensus estimate of ($0.40) by ($0.13). Albemarle had a positive return on equity of 0.41% and a negative net margin of 10.74%.The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion. During the same period in the prior year, the company earned ($1.09) earnings per share. The firm’s quarterly revenue was up 15.9% on a year-over-year basis.

Other research analysts have also recently issued research reports about the stock. UBS Group increased their target price on shares of Albemarle from $185.00 to $205.00 and gave the stock a “buy” rating in a report on Monday, January 12th. Rothschild & Co Redburn increased their price objective on shares of Albemarle from $158.00 to $185.00 and gave the stock a “buy” rating in a research note on Tuesday, February 10th. Jefferies Financial Group lifted their target price on Albemarle from $210.00 to $230.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Dbs Bank increased their price target on Albemarle from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Friday, October 24th. Finally, Citigroup boosted their price target on Albemarle from $180.00 to $190.00 and gave the stock a “neutral” rating in a research report on Friday, February 13th. Three research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $167.52.

Albemarle Trading Up 1.2%

NYSE:ALB opened at $170.92 on Thursday. The company has a market cap of $20.14 billion, a P/E ratio of -29.73, a price-to-earnings-growth ratio of 1.88 and a beta of 1.44. Albemarle has a twelve month low of $49.43 and a twelve month high of $195.68. The business has a 50 day moving average price of $160.48 and a two-hundred day moving average price of $117.44. The company has a quick ratio of 1.57, a current ratio of 2.23 and a debt-to-equity ratio of 0.41.

Institutional Investors Weigh In On Albemarle

Large investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC grew its position in shares of Albemarle by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 2,954,331 shares of the specialty chemicals company’s stock worth $184,782,000 after purchasing an additional 59,104 shares in the last quarter. ProShare Advisors LLC boosted its stake in shares of Albemarle by 48.5% in the second quarter. ProShare Advisors LLC now owns 2,870,110 shares of the specialty chemicals company’s stock valued at $179,870,000 after buying an additional 937,538 shares during the period. Earnest Partners LLC increased its stake in Albemarle by 14.6% during the 4th quarter. Earnest Partners LLC now owns 1,630,394 shares of the specialty chemicals company’s stock worth $230,603,000 after acquiring an additional 207,770 shares during the period. Manning & Napier Advisors LLC acquired a new position in Albemarle in the 3rd quarter valued at $138,723,000. Finally, Dimensional Fund Advisors LP lifted its position in shares of Albemarle by 3.7% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,475,832 shares of the specialty chemicals company’s stock valued at $119,710,000 after acquiring an additional 52,698 shares during the period. Institutional investors own 92.87% of the company’s stock.

About Albemarle

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.